Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaigham Abbas

Showing results (241-250 of 273) with videos related to

Pageof 28
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 26, 2025
First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agentRaghavendra S Patwardhan, Zaigham Abbas Rizvi, Vikram Gota, et al.
Hepatology International|July 9, 2021
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Akash Shukla, Ananta Shreshtha, Amar Mukund, et al.
Inflammatory Bowel Diseases|August 21, 2010
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meetingDaniel C Baumgart, Charles N Bernstein, Zaigham Abbas, et al.
Journal of Clinical Gastroenterology|February 8, 2014
World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013Muhammed Umar, Aamir G Khan, Zaigham Abbas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2017
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)Anika Wranke, Lourdes M Pinheiro Borzacov, Raymundo Parana, et al.
Frontiers in Immunology|February 6, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamstersJyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Hepatology International|February 3, 2022
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyManoj Kumar, Zaigham Abbas, Milad Azami, et al.
Hepatology International|March 9, 2024
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infectionsTao Chen, Guang Chen, Guiqiang Wang, et al.
Hepatology International|October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 updateGamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
Pageof 28

Showing results (241-250 of 273) with videos related to

Sort By:
Pageof 28
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 26, 2025
First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agentRaghavendra S Patwardhan, Zaigham Abbas Rizvi, Vikram Gota, et al.
Hepatology International|July 9, 2021
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Akash Shukla, Ananta Shreshtha, Amar Mukund, et al.
Inflammatory Bowel Diseases|August 21, 2010
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meetingDaniel C Baumgart, Charles N Bernstein, Zaigham Abbas, et al.
Journal of Clinical Gastroenterology|February 8, 2014
World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013Muhammed Umar, Aamir G Khan, Zaigham Abbas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2017
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)Anika Wranke, Lourdes M Pinheiro Borzacov, Raymundo Parana, et al.
Frontiers in Immunology|February 6, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamstersJyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Hepatology International|February 3, 2022
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyManoj Kumar, Zaigham Abbas, Milad Azami, et al.
Hepatology International|March 9, 2024
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infectionsTao Chen, Guang Chen, Guiqiang Wang, et al.
Hepatology International|October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 updateGamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
Pageof 28